Head of Nonclinical ADME/DMPK Strategy - Boston; Hybrid
Listed on 2026-10-12
-
Healthcare
-
Business
Scorpion Therapeutics is seeking a Lead in nonclinical ADME/DMPK to guide development for small molecules and peptides from discovery through late-stage trials. Hybrid work setup with some travel, based in Boston area.
The role requires a PhD and 10+ years in industry, with demonstrated leadership in PK/PD, DMPK, and regulatory submissions. You will drive cross-functional collaboration and strategic decision-making across programs.
We are looking to fill the Head of Nonclinical ADME/DMPK Strategy
- Boston (Hybrid) position at Rhythm Pharmaceuticals Inc. in Boston, MA, United States.
Our team is growing, and we are hiring a Head of Nonclinical ADME/DMPK Strategy
- Boston (Hybrid) in Boston, MA, United States.
This role is for the Head of Nonclinical ADME/DMPK Strategy
- Boston (Hybrid) role at Rhythm Pharmaceuticals Inc.
We are seeking a motivated Head of Nonclinical ADME/DMPK Strategy
- Boston (Hybrid) to join Rhythm Pharmaceuticals Inc. in Boston, MA, United States.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).